Editor’s Note: This post has been updated with a response from Novartis.
Greek prosecutors continue their investigation against Novartis, which is at the center of a bribery and corruption investigation concerning allegations that the Swiss pharmaceutical company paid bribes to politicians in exchange for fixing the prices of its drugs at artificially high prices and increasing its access to the Greek market.
